Biomarker commercialisation

Biomarkers are potential prognostic, diagnostic, and treatment indicators. Despite their increasing potential for precision medicine, their development into commercial products is very challenging. The purpose of a new Baltic Sea Region (BSR) consortium is to create tools for supporting and overcoming the challenges of biomarker commercialisation.

The objectives of the BIC consortium are to create

  • a biomarker development tool for researchers
  • a screening and selection guide for TTOs
  • a framework for technology translation into clinical setting
  • new business model templates
  • a biomarker platform with access to the tools and technology presentations for matchmaking

Funding source

The project's budget is EUR 2.55 million and is co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme with EUR 1.96 million.

    Official website


Best Practice Handbook

BIC Regulatory Guide

BIC Review Tool

Valérie Daussin Laurent


97 66 62 97